Kennedy Capital Management’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-16,740
| Closed | -$623K | – | 602 |
|
|
2022
Q1 | $623K | Sell |
16,740
-97
| -0.6% | -$3.61K | 0.01% | 541 |
|
|
2021
Q4 | $966K | Sell |
16,837
-287
| -2% | -$16.5K | 0.02% | 520 |
|
|
2021
Q3 | $1.75M | Sell |
17,124
-572
| -3% | -$58.5K | 0.04% | 480 |
|
|
2021
Q2 | $1.73M | Buy |
17,696
+15,075
| +575% | +$1.47M | 0.04% | 490 |
|
|
2021
Q1 | $267K | Buy |
+2,621
| New | +$267K | 0.01% | 639 |
|
|
2020
Q4 | – | Sell |
-9,368
| Closed | -$4.51M | – | 664 |
|
|
2020
Q3 | $4.51M | Buy |
9,368
+2,797
| +43% | +$1.35M | 0.13% | 301 |
|
|
2020
Q2 | $5.1M | Buy |
6,571
+209
| +3% | +$162K | 0.15% | 268 |
|
|
2020
Q1 | $4.42M | Buy |
6,362
+1,713
| +37% | +$1.19M | 0.16% | 222 |
|
|
2019
Q4 | $4.27M | Buy |
+4,649
| New | +$4.27M | 0.1% | 379 |
|